Skip to content

MaxCyte MXCT Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$4.75M+53.7%-$9.6M+9.4%-$12.42M-7.4%-$12.36M-31.8%-$10.26M-7.7%
$1.05M-4.5%$1.07M+1.4%$1.07M+0.6%$1.1M+1.8%$1.1M-1.4%
$1.14M-62.5%$706K-77.5%$1.95M-42.0%$3.51M-1.4%$3.04M+0.8%
-$8.17M+43.3%-$2.69M+65.6%-$7.46M-69.8%-$9.85M-104%-$14.41M-36.4%
$72K-89.0%$231K+57.1%$300K-26.1%$584K+98.6%$653K-18.8%
$1.77M
$2.66M-72.1%$9.68M$5.19M+43.9%$1.54M-92.1%$9.53M+166%
$5K-98.7%$105K-74.5%$14K-93.9%$154K-78.4%$383K-45.5%
-$5.51M-22.4%-$2.25M-306%-$8.16M-$4.5M+81.5%
-$8.24M+45.3%-$2.92M+63.4%-$7.76M-61.7%-$10.44M-104%-$15.06M-32.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does MaxCyte generate?
MaxCyte (MXCT) generated -$28.2M in operating cash flow over the trailing twelve months.
What is MaxCyte's free cash flow?
After $1.2M of capital expenditures, MaxCyte's free cash flow was -$29.4M over the trailing twelve months, up 10.9% year over year.
Where does MaxCyte's cash flow data come from?
Every line is extracted from MaxCyte's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.